User login
17. US Department of Veterans Affairs, Office of Research and Development.
Parkinson’s disease. Updated October 28, 2021. Accessed May 5, 2023.
https://www.research.va.gov/topics/parkinsons.cfm
18. Feeney M et al. Front Neurol. 2022;13:924999. doi:10.3389/fneur.2022.924999
19. Heronemus M et al. Parkinsonism Relat Disord. 2022;105:58-61. doi:10.1016/j.parkreldis.2022.11.003
20. Nejtek VA et al. PLoS One. 2021;16(11):e0258851. doi:10.1371/journal.pone.0258851
21. Yang Y et al. Dement Neurocogn Disord. 2016;15(3):75-81. doi:10.12779/dnd.2016.15.3.75
17. US Department of Veterans Affairs, Office of Research and Development.
Parkinson’s disease. Updated October 28, 2021. Accessed May 5, 2023.
https://www.research.va.gov/topics/parkinsons.cfm
18. Feeney M et al. Front Neurol. 2022;13:924999. doi:10.3389/fneur.2022.924999
19. Heronemus M et al. Parkinsonism Relat Disord. 2022;105:58-61. doi:10.1016/j.parkreldis.2022.11.003
20. Nejtek VA et al. PLoS One. 2021;16(11):e0258851. doi:10.1371/journal.pone.0258851
21. Yang Y et al. Dement Neurocogn Disord. 2016;15(3):75-81. doi:10.12779/dnd.2016.15.3.75
17. US Department of Veterans Affairs, Office of Research and Development.
Parkinson’s disease. Updated October 28, 2021. Accessed May 5, 2023.
https://www.research.va.gov/topics/parkinsons.cfm
18. Feeney M et al. Front Neurol. 2022;13:924999. doi:10.3389/fneur.2022.924999
19. Heronemus M et al. Parkinsonism Relat Disord. 2022;105:58-61. doi:10.1016/j.parkreldis.2022.11.003
20. Nejtek VA et al. PLoS One. 2021;16(11):e0258851. doi:10.1371/journal.pone.0258851
21. Yang Y et al. Dement Neurocogn Disord. 2016;15(3):75-81. doi:10.12779/dnd.2016.15.3.75